SyntheticGestalt Companies
SyntheticGestalt is an organization that focuses on developing machine learning models for drug discovery and software for automating research in the life sciences sector. Their synthetic biology simulation models accurately predict the outcomes of various amino acid arrangements, streamlining the drug development process for pharmaceutical companies. Their main goal is to automate the discovery of valuable inventions, starting with drug discovery. They believe that the interaction between biotechnology and AI technology is crucial for the next industrial revolution and are actively engaged in collaborative research with industry partners to identify new drug candidates, including for COVID-19.
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
London, England, United Kingdom
Founded Date:
2018
Employees Number:
15
Register and Claim Ownership